An Expanded Access Program for AM0010 (Pegilodecakin)
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer
Interventions: BIOLOGICAL: AM0010
Sponsor: Eli Lilly and Company
Collaborators: ARMO BioSciences